SDRNFLRFamide: isolated from the nervous system of the lobster Homarus americanus; exhibits FMRFamide-like immunoreactivity [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 130730 |
| MeSH ID | M0221954 |
| Synonym |
|---|
| l-seryl-l-alpha-aspartyl-l-arginyl-l-asparaginyl-l-phenylalanyl-l-leucyl-l-arginyl-l-phenylalaninamide |
| seryl-aspartyl-arginyl-asparaginyl-phenylalanyl-leucyl-arginyl-phenylalaninamide |
| 113611-67-9 |
| ser-asp-arg-asn-phe-leu-arg-phe-nh2 |
| l-phenylalaninamide, l-seryl-l-alpha-aspartyl-l-arginyl-l-asparaginyl-l-phenylalanyl-l-leucyl-l-arginyl- |
| sdrnflrfamide |
| ser-asp-arg-asn-phe-leu-arg-phe-amide |
| (6s,9s,12s,15s,18s,21s)-1-amino-6-(((s)-1-amino-1-oxo-3-phenylpropan-2-yl)carbamoyl)-15-(2-amino-2-oxoethyl)-21-((s)-2-amino-3-hydroxypropanamido)-12-benzyl-18-(3-guanidinopropyl)-1-imino-9-isobutyl-8,11,14,17,20-pentaoxo-2,7,10,13,16,19-hexaazatricosan-2 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.34) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||